The biNV-IL-15 treatment induced much higher TNF-α and IFN-γ secretion than IL-15+biNV in 4T1 and CT26 tumor models (Fig. 5g, h, Supplementary Fig. 8h, i). The gene discussed is IL15; the disease is neoplasm.